A significant portion of patients with multiple sclerosis (MS) can achieve a stable disease state when treated with modern disease-modifying therapy (DMT), especially when started early in the disease ...

Multiple sclerosis (MS) is a devastating autoimmune disease that destroys the protective myelin covering around nerves, disrupting communication between the brain and body, and causing patients' ...

Researchers from Bonn and Erlangen identify the protein MLC1 as a target antigen in multiple sclerosis (MS); a chronic inflammatory disease of the central nervous system caused by the immune system. B ...

A stem cell treatment commonly used for blood cancer appears effective in treating one form of MS The treatment has been available since the 1990s but questions about safety and difficulty have ...

JT Lew, PharmD, MBA, managed care pharmacist at MultiCare Health System, spoke to the impacts of processes such as prior authorization and step therapy requirements in the realm of multiple sclerosis ...

STOCKHOLM ― Until their mid to late 30s, some people with multiple sclerosis (MS) can better compensate for damage to their central nervous system, new evidence suggests. Thereafter, at about age 40, ...

Share on Pinterest Researchers are looking into stem cell therapy as a potential treatment for multiple sclerosis. Andrew Brookes/Getty Images Multiple sclerosis is an autoimmune disease that affects ...

In the brain section of an MS patient, the neurons are shown in green and the target antigen MLC1 in red. Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system caused ...

Purposive-sampled Dutch interviews (n=23; median age 50; median MS duration 13 years) showed near-universal experience with physiotherapy and substantial occupational therapy exposure among ...

(BOSTON) — Multiple sclerosis (MS) is a devastating autoimmune disease that destroys the protective myelin covering around nerves, disrupting communication between the brain and body, and causing ...